Abstract

The aim of this study is to propose an improved computational methodology, which is called Compressed Images for Affinity Prediction-2 (CIFAP-2) to predict binding affinities of structurally related protein–ligand complexes. CIFAP-2 method is established based on a protein–ligand model from which computational affinity information is obtained by utilizing 2D electrostatic potential images determined for the binding site of protein–ligand complexes. The quality of the prediction of the CIFAP-2 algorithm was tested using partial least squares regression (PLSR) as well as support vector regression (SVR) and adaptive neuro-fuzzy ınference system (ANFIS), which are highly promising prediction methods in drug design. CIFAP-2 was applied on a protein–ligand complex system involving Caspase 3 (CASP3) and its 35 inhibitors possessing a common isatin sulfonamide pharmacophore. As a result, PLSR affinity prediction for the CASP3–ligand complexes gave rise to the most consistent information with reported empirical binding affinities (pIC50) of the CASP3 inhibitors.

Highlights

  • Significant progress has been made by scientists towards understanding diseases at molecular levels by developing new methods in the field of genomics, proteomics as well as medicine

  • The aim of this study is to propose an improved computational methodology, which is called Compressed Images for Affinity Prediction-2 (CIFAP-2) to predict binding affinities of structurally related protein–ligand complexes

  • Compressed Images for Binding Affnity Prediction (CIFAP)-2 method is established based on a protein–ligand model from which computational affinity information is obtained by utilizing 2D electrostatic potential images determined for the binding site of protein–ligand complexes

Read more

Summary

Introduction

Significant progress has been made by scientists towards understanding diseases at molecular levels by developing new methods in the field of genomics, proteomics as well as medicine. Increasing stored knowledge of drug actions at a molecular level renders development of some novel drugs which are safer and more efficient in medical treatments[1]. Understanding protein–ligand interactions at a molecular level is important to design new drugs which are safe and efficient. Computational methods such as docking and molecular dynamics have become powerful, time-saving and cheaper methods for providing detailed information on protein–ligand interactions. Intelligent computational methods have recently become popular in drug design[2,3,4,5,6,7,8,9,10].

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.